A Pilot Study of Blood-based Biomarkers for Response to Immune Checkpoint Inhibitors

RecruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

September 2, 2020

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions

Non-Small Cell Lung CancerRenal Cell Carcinoma (RCC)

Interventions

OTHER

Biospecimen Collection

Undergo collection of blood and stool samples

Trial Locations (1)

RECRUITING

The Ohio State University Comprehensive Cancer Center, Columbus

All Listed Sponsors

lead

Ohio State University Comprehensive Cancer Center

OTHER